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Abstract  The  current  Zika  virus  outbreak  in  the  Americas  and  the  proposed  link
to  increases  in  microcephaly  and  neurological  disorders  have  prompted  the  World
Health  Organization  to  declare  a Public  Health  Emergency  of  International  Concern
on  February  1,  2016.  The  virus  is  transmitted  by  Aedes  mosquitoes  and  potentially
by  transfusion,  perinatal  and  sexual  transmission.  The  potential  for  spread  into
countries  where  Aedes  mosquitoes  are  endemic  is  high.  Previously,  cases  tended
to  be  sporadic  and  associated  with  mild,  non-speciﬁc  symptoms.  Prior  outbreaks
occurred  in  Yap  Island  in  Micronesia  in  2007,  the  ﬁrst  time  Zika  arose  outside  of  Africa
and  Asia,  and  in  French  Polynesia  in  2013.  A  birth  data  review  has  conﬁrmed  that  the
latter  outbreak  was  followed  by  an  increase  in  microcephaly  cases.  A  coordinated
international  response  is  needed  to  address  mosquito  control;  expedite  develop-
ment  of  diagnostic  tests,  vaccines  and  speciﬁc  treatments  for  Zika;  and  address  the
proposed  link  to  microcephaly  and  neurological  diseases.
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Introduction
International  interest  in  the  Zika  virus  (ZIKV)  has
been sparked  by  the  current  outbreak  in  Brazil
and other  countries  in  the  Americas,  which  led  the
Pan American  Health  Organization  to  issue  an  alert
for northeast  Brazil  on  7  May  2015.  The  world-
wide interest  is  largely  due  to  a  possible  link  to
an increased  incidence  of  microcephaly  and  neuro-
logical  disorders,  including  Guillain-Barré  syndrome
(GBS),  in  the  affected  areas.  No  causative  link
has yet  been  scientiﬁcally  established;  however,
the World  Health  Organization  (WHO)  strongly  sus-
pects that  the  concomitance  of  a  sharp  increase
of microcephaly  and/or  GBS  incidence  in  seven
countries in  the  Americas  and  the  ZIKV  out-
break indicates  a  relationship.  This  possibility
has led  them  to  declare  a  Public  Health  Emer-
gency of  International  Concern  on  February  1,
2016 [1].
ZIKV is  a  mosquito-borne  virus,  but  other  forms
of transmission,  including  by  blood  transfusion
and probable  sexual  and  perinatal  transmission,
have also  been  conﬁrmed  [1—5].  Concern  has
been heightened  further  in  the  face  of  upcom-
ing mass  gatherings  in  regions  where  the  virus  is
currently  endemic,  such  as  the  Summer  Olympics
in Brazil  [6].  The  Umrah  and  Haji  pilgrimages
in Saudi  Arabia,  where  local  mosquito  popula-
tions represent  the  potential  for  new  outbreaks,
are also  major  concerns  [7]. The  current  lack
of speciﬁc  treatments  or  vaccines  and  compli-
cations in  diagnosis  of  ZIKV  further  underscore
the urgency  of  developing  a  global  approach  to
researching  this  virus  [8—11]. The  objective  of  this
paper is  to  give  an  overview  of  the  history  of  the
History of Zika epidemiology
The  ZIKV  is  a mosquito-borne  Flavivirus, of  the
family  Flaviviridae. It was  ﬁrst  isolated  from  a
febrile sentinel  monkey  in  the  Zika  forest  in  Uganda
in 1947  and  subsequently  from  Aedes  africanus
mosquitoes in  the  same  forest  [12,13].  Isolation
of ZIKV  from  Ae.  africanus  mosquitoes  and  other
Aedes species  including  Ae.  aegypti  in  Africa  and
Malaysia  over  the  subsequent  decades  followed  [2].
Many other  Aedes  species,  including  Ae.  luteo-
cephalus, Ae.  albopictus,  Ae.  furcifer,  Ae.  vittatus,
Ae. taylori,  Ae.  dalzieli,  Ae.  hirsutus,  Ae.  metal-
licus, Ae.  hensilii  and  Ae.  unilineatus  have  also
been implicated  as  vectors,  as  have  mosquitoes
from other  genera,  including  Mansonia  uniformis,
Culex perfuscus  and  Anopheles  coustani  [14,15].
Cases of  ZIKV  infection  of  humans  arose  through-
out the  1960s  and  1970s  in  several  countries  in
Africa and  Asia  [2]. Although  the  cases  were  spo-
radic, they  were  widespread.  The  true  incidence
and prevalence  of  ZIKV,  however,  remains  difﬁcult
to deﬁnitively  establish  because  of  the  lack  of  sim-
ple, reliable  laboratory  diagnostic  tests  and  the
similarity  of  symptoms  caused  by  ZIKV  to  those  of
other arbovirus  infections  [16].
The  ﬁrst  example  of  human  infection  by  ZIKV  out-
side of  Africa  and  Asia  arose  in  2007,  when  there
was an outbreak  in  Yap  Island  in  the  Federated
States of Micronesia  in  Oceania.  [2].  Yap  Island  has
a population  of  approximately  7391  people;  49  pos-
itive cases  and  59  probable  cases  of  ZIKV  infection
were identiﬁed  using  ELISA  to  detect  IgM  antibody
against ZIKV  or  by  identiﬁcation  of  ZIKV  RNA  [8].
A household  survey  suggested  prevalence  of  75%
of the  population  over  the  age  of  three  [1,8,17].Please  cite  this  article  in  press  as:  Rabaan  AA,  et  al.  Overv
control  measures.  J  Infect  Public  Health  (2016),  http://dx.d
ZIKV and  of  current  understanding  of  the  virology,
symptoms, transmission,  diagnosis  and  treatment
of this  virus,  along  with  consideration  of  future
perspectives.
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be. hensilli,  the  predominant  Aedes  species  on  Yapiew  of  Zika  infection,  epidemiology,  transmission  and
oi.org/10.1016/j.jiph.2016.05.007
sland, has  been  identiﬁed  in  laboratory  studies  as
 likely  culprit  for  the  ZIKV  vector  during  that  out-
reak [14].
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verview  of  Zika  infection,  epidemiology,  transmiss
The  previously  largest  documented  ZIKV  out-
reak occurred  in  2013  in  French  Polynesia,  a
rench overseas  territory  in  the  South  Paciﬁc  with
 population  of  approximately  268,000  people.  Up
o 8200  ZIKV  infection  cases  were  reported,  with  an
stimated  prevalence  of  10−11%  [4,10,16—18].
Thus far,  in  the  current  outbreak,  33  countries
ave reported  autochthonous  Zika  virus  transmis-
ion between  January  2014  and  February  2016,
ost notably  Brazil  and  Colombia.  In  addition,
ix countries  are  reporting  the  indirect  evidence
f transmission  of  the  virus  [1,6,11].  ZIKV  appears
o be  spreading  globally  in  a  similar  manner
o other  arbovirus  family  members,  including
engue (DENV)  and  chikungunya  (CHIKV)  viruses
19].
ika virology and symptoms
IKV  is  an  emerging  arbovirus  member  of  the
lavivirus genus  of  the  Flaviviridae  family.  The
lavivirus  genus  comprises  more  than  70  viruses,
lso including  DENV,  Yellow  Fever  virus  (YFV),
apanese encephalitis  virus  (JEV)  and  West  Nile
irus (WNV).  As  with  the  other  ﬂaviviruses,  ZIKV
s a  positive,  single-stranded  RNA  virus  and  has
 10,794  nucleotide  genome.  Its  genome  consists
f 5′ and  3′ untranslated  regions  ﬂanking  an  open
eading  frame  which  encodes  a  polyprotein  of
hree structural  proteins,  namely  the  capsid  (C),
remembrane/membrane  (prM)  and  envelope  (E),
nd seven  non-structural  proteins,  i.e.  NS1,  NS2A,
S2B,  NS3,  NS4A,  2K,  NS4B  and  NS5  [20,21].  Phy-
ogenetic  analysis  of  ZIKV  isolates  from  Cambodia,
alaysia, Nigeria,  Uganda  and  Senegal,  along  with
ther published  ZIKV  sequences,  suggests  that  there
re two  main  ZIKV  lineages,  Asian  and  African.  The
ap Island  outbreak,  for  example,  was  caused  by
 strain  originating  in  Southeast  Asia  [21]. Use  of
eal-time  PCR  on  isolates  from  the  2007  outbreak
howed that  the  envelope  protein  contained  an
sn-X-Ser  glycosylation  motif  at  position  154,  which
s found  in  many  ﬂaviviruses,  but  not  the  prototype
R766 ZIKV  strain  [2,21]. Loss  of  this  glycosylation
ite may  represent  a  polymorphism  among  circulat-
ng strains  but  may  also  reﬂect  passaging  history  of
trains [21].
Symptoms  associated  with  ZIKV  infection  are
ariable. It  is asymptomatic  in  up  to  80%  of
ases [8,11,22],  and  when  symptoms  do  occur,Please  cite  this  article  in  press  as:  Rabaan  AA,  et  al.  Overv
control  measures.  J  Infect  Public  Health  (2016),  http://dx.d
hey are  typically  mild  and  non-speciﬁc.  These
nclude mild  fever,  conjunctivitis,  maculopapular
ash, myalgia  and  headache  [23]. In  the  Yap  Island
utbreak,  for  example,  patients  suffered  from  rash,
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onjunctivitis  and  arthralgia  [2,8].  This  leads  to  the
otential misdiagnosis,  for  example,  as  DENV  infec-
ion. However,  in  the  current  outbreak,  a  potential
ink has  been  identiﬁed  between  ZIKV  infection  and
n increase  in  some  serious  neurological  effects,
uch as  GBS  and  microcephaly.  Microcephaly  is  a
are condition  in  which  the  circumference  of  the
aby’s head  is  smaller  than  expected,  and  it  is
sually a  result  of  the  failure  of  normal  brain  devel-
pment  in  utero.  This  may  be  due  to  toxins  or
nfections. GBS,  meanwhile,  is  an  acute  neural  ill-
ess which  results  in  a deﬁcit  in  lower,  bilateral  and
ymmetrical  sensorimotor  development  [1]. Other
aviviruses  are  associated  with  neurological  disor-
ers. For  example,  JEV  is  the  main  cause  of  vaccine-
reventable  encephalitis  in  Asia  and  the  western
aciﬁc [24].
In  Brazil,  for  example,  an  average  of  163  cases
f microcephaly  were  recorded  annually  between
001 and  2014;  however,  in  the  year  up  to  January
0, 2016,  4783  microcephaly  and/or  CNS  mal-
ormation cases  had  already  been  recorded  [1].
razil, Colombia,  El  Salvador  and  Suriname  have  all
lso reported  sharp  increases  in  GBS  cases  during
he course  of  2015  up  to  the  present,  concur-
ent with  the  ZIKV  outbreak  [1].  In  Brazil,  for
xample, of  the  42  patients  conﬁrmed  to have
BS in  Bahia  state  in  July  2015,  62%  had  pre-
ious symptoms  consistent  with  ZIKV  infection.
iven the  putative  link  between  microcephaly  and
IKV uncovered  by  this  outbreak,  the  French  Poly-
esian authorities  have  carried  out  a  review  of
irth data  for  children  born  between  March  2014
nd May  2015,  after  their  outbreak  began.  Eigh-
een cases  of  CNS  malformation,  including  nine
icrocephaly  cases,  have  been  identiﬁed  as  a
esult, in  striking  contrast  to  the  usual  aver-
ge annual  rate  of 0−2  microcephaly  cases  [1].
hile no  deﬁnitive  link  has  yet  been  proven,  one
ecent  molecular  genetics  and  electron  microscopic
tudy demonstrated  the  presence  of  ZIKV  in  fetal
rain  matter,  but  not  other  organs,  of  an  aborted
etus with  microcephaly.  The  mother  was  a Euro-
ean woman  who  had  been  infected  with  ZIKV  at
3 weeks  gestation  while  working  in  northeastern
razil [25,26].
The  French  Polynesia  outbreak  also  yielded  the
rst report  of  a case  of  GBS  complication  of  a  ZIKV
nfection  [16]. DENV  has  also  been  associated  with
BS, and  prior  DENV  infection  may  pre-dispose  a
IKV patient  to  GBS.  Ultimately,  the  GBS  incidence
n French  Polynesia  was  estimated  to  have  riseniew  of  Zika  infection,  epidemiology,  transmission  and
oi.org/10.1016/j.jiph.2016.05.007
0-fold following  the  ZIKV  outbreak  [16]. Clearly,
his potential  link  between  ZIKV  and  serious  neu-
ological  disorders  has  focused  attention  on  viral
ransmission.
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ZIKV transmission
As  mentioned,  in  common  with  other  ﬂaviviruses,
ZIKV is  transmitted  by  female  mosquito  vectors.
The mosquito  acquires  the  virus  during  a blood
meal. The  ZIKV  can  then  breed  in  the  mosquito,
which is not  killed  by  the  virus,  and  it  is  transmit-
ted to  humans  during  a  subsequent  blood  meal  by
injection  into  the  skin  and  infection  of  permissive
skin cells  [22,27]. ZIKV  is  circulated  predominantly
via a  sylvatic  cycle  involving  mainly  non-human
primates and  arboreal  mosquitoes,  most  notably
Aedes  species,  for  example,  in  the  forests  of
Africa and  Asia.  However,  an  urban  cycle  involving
humans and  species  such  as  Ae.  aegypti,  Ae.  hen-
silli or  Ae.  albopictus  has  now  been  well  established
to exist  in  Africa,  Asia,  Oceania  and  the  Ameri-
cas [2,4,8,14,15,17,19]. Transmission  by  Aedes  and
other mosquitoes  opens  up  the  possibility  of  spread
of ZIKV  into  any  region  where  such  vectors  might  be
present,  including  Southern  Europe  and  the  United
States  [1,10,11,17,19].  There  have  been  reported
cases  of  importation  of  ZIKV  into  Australia  by  people
traveling  from  Indonesia  and  the  Cook  Islands  and
into Canada  by  travelers  from  Thailand  [27—29].
Recent cases  of  importation  of  ZIKV  to  Europe  have
also been  reported  into  France  by  three  travelers  to
Martinique,  Brazil  and  Colombia  [30];  into  Italy  by
travelers to  Brazil  [31]  and  French  Polynesia  [32];
and into  Germany  by  a  traveler  to  Thailand  [33].
In another  case  from  January  2016,  a  baby  born
with microcephaly  in  Oahu,  Hawaii,  was  conﬁrmed
by the  CDC  to  have  been  infected  with  ZIKV.  The
child’s mother  probably  acquired  the  virus  in  May
2015 in  Brazil  and  passed  the  infection  perina-
tally to  her  child  [1]. Further  evidence  of  perinatal
ZIKV transmission  came  from  clinical  and  labora-
tory studies  on  two  mothers  and  their  newborns
in French  Polynesia  in  2014  [4].  Both  mothers  had
ZIKV infections,  with  conﬁrmation  in  the  newborns
by RT-PCR  within  4  days  of  delivery.  Transmission
most likely  occurred  either  transplacentally  or  dur-
ing delivery  [4].  The  potential  for  ZIKV  transmission
via blood  transfusion  was  also  demonstrated  during
the French  Polynesia  outbreak  [5].  This  is  particu-
larly concerning  given  that  ZIKV  infection  is  so  often
asymptomatic;  therefore,  blood  donors  may  not  be
aware of  their  potentially  infective  status.
There  is  also  some  limited  evidence  from  case
studies that  ZIKV  can  be  sexually  transmitted.  Dur-
ing the  French  Polynesia  outbreak,  ZIKV  RNA  was
detected  by  RT-PCR  from  semen  and  urine  samples,Please  cite  this  article  in  press  as:  Rabaan  AA,  et  al.  Overv
control  measures.  J  Infect  Public  Health  (2016),  http://dx.d
but not  in  blood  samples,  from  a  patient  in  Tahiti
who had  two  episodes  of  symptoms  consistent  with
ZIKV and  subsequently  presented  with  hematosper-
mia [3].  The  ZIKV  was  detected  in  samples  taken
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−3  days  after  he  presented  with  hematospermia;
ulturing of  the  samples  revealed  replicative  viral
articles  in  the  semen  but  not  the  urine  samples.
hese results  were  consistent  with  observations  in
 previous  case  of  a man  from  the  United  States
ho contracted  ZIKV  while  travelling  in  Senegal
34]. Four  days  after  returning  to  the  US,  he  had
ymptoms  of  hematospermia,  while  his  wife,  with
hom he  had  sexual  intercourse  on  the  ﬁrst  day
f his  return,  was  suffering  from  ZIKV  symptoms.
IKV infection  was  conﬁrmed  serologically  in  both
pouses,  and  although  the  man’s  semen  was  not
ormally  tested,  sexual  transmission  seemed  the
ost likely  route.  Other  probable  case  of  sexual
ransmission has  been  noted  in  Italy  in  a female
artner of  a  man  who  had  travelled  to  Thailand
35]. The  identiﬁcation  of  probable  sexual  trans-
ission  of  ZIKV  has  led  to  the  recent  publication  by
he CDC  (February  5,  2016)  of  recommendations  for
revention of  ZIKV  sexual  transmission,  especially
or pregnant  women.  It  recommends  that  men  who
eside in  or  have  travelled  to  an  area  of  ongoing
IKV transmission  and  whose  partner  is  pregnant
hould abstain  from  sexual  activity  or  use  condoms
uring sexual  activity  throughout  the  pregnancy
36].
IKV transmission and mass gatherings
he  ready  transmission  of  ZIKV  via  mosquito  bites,
ombined  with  the  possibilities  of  sexual  and  peri-
atal transmission,  have  raised  fears  regarding
p-coming mass  gatherings  in  areas  where  the  virus
s currently  endemic  and  other  areas  where  local
edes  mosquito  populations  provide  potential  vec-
ors for  new  outbreaks.  Potentially  most  signiﬁcant
s the  summer  Olympics,  which  will  take  place
n Brazil  from  August  5−21  2016  and  is  likely  to
ttract millions  of  people  both  from  within  Brazil
nd from  other  countries,  along  with  the  Para-
ympics, due  to  take  place  between  September  8
nd September  13  [6,7]. The  type  of  young  and
ealthy, middle-to  high-income  group  of  interna-
ional  travelers  most  likely  to  attend  the  Olympics
re less  likely  to  have  been  previously  exposed  to
IKV or  other  arboviruses  [7]. They  are  also  perhaps
ess likely  to  be  aware  of  basic  precautions  against
osquito  bites,  such  as  wearing  suitable  protec-
ive clothing,  optimal  use  of  EPA-approved  insect
epellents  and  use  of  mosquito  nets  while  sleeping.iew  of  Zika  infection,  epidemiology,  transmission  and
oi.org/10.1016/j.jiph.2016.05.007
hey  may  also  be  potentially  more  vulnerable  to
ossible sexual  transmission  of  ZIKV  [7]. This  has
erious implications  for  Public  Health  Preparedness
n the  context  of  the  Olympics,  and  underscores  the
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eed  for  a  coordinated  international  response  to
urveillance,  prevention  and  limiting  the  spread  of
isease at  events  associated  with  mass  gatherings
6].  In  terms  of  the  Olympics,  the  organizers  have
mplemented  plans  to  control  vectors  in  the  vicin-
ty of  the  Games  [6,7]. However,  a  combination  of
ersonal and  community  measures  is  necessary,  as
ell as  a  coherent  public  health  policy,  to  mini-
ize risk  of  ZIKV  transmission  either  by  mosquito
ites or  other  means  [7]. It  is  recommended  that
ravelers  to  the  Olympics  consult  their  family  doc-
or and/or  travel  medicine  providers  in  advance  of
ravelling and  acquaint  themselves  with  all  up-to-
ate health  information  and  relevant  precautions,
ncluding on  ZIKV,  by  consulting  agencies  such  as  the
atin American  Society  for  Travel  Medicine  (SLAMVI)
r their  own  country’s  public  health  agencies.  Given
he status  of  ZIKV  as  a  blood-borne  disease,  it is
ital that  local  medical  facilities  are  prepared,  with
asic infection  control  strategies  in  place,  including
igorous hand  hygiene  practice;  contact  precau-
ions; safe  disposal  practices  for  sharps,  blood  and
ther body  ﬂuids  and  disposable  instruments;  and
dequate  sterilization  practices  for  non-disposable
nstruments [6].
The  CDC  has  already  issued  interim  guidelines
ertaining  to  the  ZIKV  to  pregnant  women  [22].
hey have  recommended  that  pregnant  women  or
hose considering  pregnancy  postpone  travelling  to
ountries with  ongoing  ZIKV  transmission.  If this
s not  possible,  they  must  follow  the  strictest  of
teps to  avoid  mosquito  bites  both  outdoors  and
ndoors,  especially  during  the  day,  when  the  Aedes
osquitoes  are  most  likely  to  bite  [6,22].
The timing  of  the  summer  Olympics,  which  is
ctually during  the  time  of  winter  temperatures
n Brazil,  means  that  mosquito  populations  will  be
ower than  at  other  times  of  the  year,  helping  to
itigate  the  potential  risk  of  ZIKV  spread.  However,
here are  other  mass  gatherings  scheduled  to  occur
lsewhere  in  the  world  in  which  Aedes  populations
resent a  potential  new  outbreak  vector.  For  exam-
le, in  Saudi  Arabia,  the  Umrah  (June  to  September,
016) and  Haji  (8th−13th  September,  2016)  pilgrim-
ges are  due  to  take  place.  These  events  will  attract
pwards  of  7  million  pilgrims  from  nearly  200
ountries, including  thousands  from  Latin  Amer-
ca [7].  The  proﬁle  of  these  pilgrims  will  tend  to
e older  adults  from  lower-income  countries,  and
hey therefore  present  different  Public  Health  Pre-
aredness  challenges  compared  to  the  Olympics
ttendees [7].  Saudi  Arabia  is  well-accustomed  toPlease  cite  this  article  in  press  as:  Rabaan  AA,  et  al.  Overv
control  measures.  J  Infect  Public  Health  (2016),  http://dx.d
reparing for  the  public  health  challenges  posed
y such  pilgrimages  and  routinely  convenes  annual
nternational  public  health  consultations  to  address
elevant  disease-speciﬁc  issues;  this  year,  ZIKV  will
t
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eature  high  on  this  list.  It  is  routine  to  provide
ealth advice  on  an  individual  level  to  pilgrims  in
dvance of  traveling,  with  reinforcement  of  advice
t points  of  both  departure  and  arrival,  and  arrang-
ng for  distribution  of  methods  of  prevention,  such
s mosquito  nets  and  insect  repellent  [7].  Such
easures  would  be  directly  relevant  in  Brazil  dur-
ng the  run-up  to  the  Olympics,  with  issues  including
hortages  of  insect  repellent  to  be  met  in  advance
hrough international  collaboration.  Saudi  Arabia
as experience  in  the  application  of  public  health
easures  for  prevention  of  disease  in  the  context
f mass  pilgrimages  in  the  past,  for  example,  during
he H1N1  pandemic  in  2009.
ontrol measures
he  WHO  has  identiﬁed  Aedes  mosquitoes,  for
xample  Ae.  aegypti,  as  particularly  tenacious
ests, which  have  readily  adapted  to  changing  envi-
onments  such  as  increased  urbanization  [37,38].
nfortunately,  reductions  in  mosquito  control  pro-
rams during  the  1960s  led  to  consequent  loss  of
xpertise,  resources  and  infrastructure.  Now  there
s a tendency  toward  emergency-driven  reactions,
or example,  reactive  spraying/fogging  with  insec-
icides. However,  this  type  of  approach  is  neither
ustainable nor  effective  in  the  long-term,  partic-
larly  as  mosquitoes  develop  resistance  to  more
nsecticides  [37].
The  WHO  Emergency  Committee  on  ZIKV  made
arious recommendations  on  how  the  spread  of  this
irus could  be  potentially  be  controlled,  which  is
articularly  important  in  the  current  absence  of  a
accine or  speciﬁc  treatment  [1,37]. Some  of  the
ecommendations  pertain  to  personal  and  house-
old protection,  such  as  the  measures  mentioned
bove to  avoid  mosquito  bites,  including  the  use
f EPA-approved  insect  repellents;  wearing  light-
olored protective  clothing  to  keep  as  much  as
ossible  of  the  body  covered;  using  physical  barri-
rs such  as  screens  and  closing  doors  and  windows;
sing mosquito  nets  to  sleep  under,  especially  when
he mosquitoes  are  most  active  in  the  daytime;  and
voiding collection  of  stagnant  water  in  containers
uch as  buckets,  used  tires,  water  barrels  or  ﬂower
ots [1,17,37]. Other  control  measures  include  the
ype of  travel  advice  issued  by  the  CDC  to  pregnant
omen, or  those  considering  pregnancy  [11,22].
owever, other  recommendations  have  addressediew  of  Zika  infection,  epidemiology,  transmission  and
oi.org/10.1016/j.jiph.2016.05.007
he need  to  improve  mosquito  control  programs,
ncluding the  use  of  larvicides  for  treatment  of
tanding  water  that  cannot  be  otherwise  cleaned,
overed or  emptied  [1,37].
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The  WHO,  overall,  recommends  an  integrated
approach, in  which  the  mosquitoes  are  targeted
at all  life  stages,  not  just  via  fogging  of  adults
with insecticides  such  as  Deltamethrin  [17].  Fogging
would only  be  recommended  during  emergencies
and should  be  conducted  around  dawn  and  dusk,
when mosquitoes  are  most  active  [37,38]. More
innovative,  newer  tools  are  also  being  considered
by a  WHO  Vector  Control  Advisory  Group.  These
include the  recommendation  of  further  ﬁeld  tri-
als and  risk  assessment  of  the  OX513A  transgenic
mosquito. Introduction  of  male  OX513A  mosquitoes
gained some  success  in  the  reduction  of  the  Ae.
aegypti population  in  the  Cayman  Islands  and  in
a suburb  of  Juazeiro,  Bahia,  Brazil  [39].  Other
approaches under  consideration  include  the  mass
release  of  radiation-sterilized  males,  which  will
mate with  females  who  will  lay  non-viable  eggs
[40,41].  Yet  another  approach  could  exploit  the
naturally  occurring  Wolbachia  bacteria,  by  super-
infection  of  Aedes  mosquitoes  with  strains  of
Wolbachia  [42].  If  a  female  mosquito  mates  with
a Wolbachia-carrying  male,  she  will  lay  non-viable
eggs. In  El  Salvador,  meanwhile,  there  are  plans
to introduce  ﬁsh  that  eat  mosquito  larvae  into
water storage  containers.  Thus,  beyond  conven-
tional  mosquito  control  strategies,  the  WHO  is
encouraging  the  development  of  potential  new
strategies  that  do  not  rely  on  pesticides  [1,37].
It is  more  important  than  ever,  therefore,  that
research  continues  on  innovative  methods  for
potentially  reducing  mosquito  populations.  In  one
recent study,  for  example,  researchers  identiﬁed
a Chromobacteria  family  member  termed  Csp  P  in
the gut  microbiota  of  Aedes  aegypti  mosquitoes
[43].  When  mosquitoes  ingested  Csp  P  bacteria,
Csp P  bioﬁlms  colonized  the  mid-gut.  This  colo-
nization reduced  mosquito  susceptibility  to  DENV
and Plasmodium  falciparum  infection  and  reduced
the lifespan  of  both  mosquito  larvae  and  adults.
The Csp  P  also  had  direct  in  vitro  anti-DENV  and
anti- P.  falciparum  activities  in  the  absence  of
mosquitoes.  Such  studies  open  up  the  possibility  of
exploiting mosquito  gut  microbiota  elements  and
using them  against  the  mosquito,  as  well  as  poten-
tially for  use  as  direct  therapies  against  viruses
spread by  mosquitoes,  including  ZIKV.  Another
approach, which  was  ﬁrst  proposed  as  a theory
more than  60  years  ago,  is  to  induce  sex  distortion  in
the mosquito  population,  to  tip  the  balance  toward
the non-biting  male  mosquitoes,  thus  reducing  dis-
ease spread  and  ultimately  depleting  mosquitoPlease  cite  this  article  in  press  as:  Rabaan  AA,  et  al.  Overv
control  measures.  J  Infect  Public  Health  (2016),  http://dx.d
populations. For  example,  in  one  study,  a slime
mold  endonuclease  called  I-Ppol  selectively  shred-
ded the  X  chromosome  of  the  malaria  mosquito
vector, Anopheles  gambiae  [44]. Male  mosquitoes
p
a
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ere  genetically  engineered  to  heritably  produce
-Ppol during  spermatogenesis  and  hence  pro-
uced hardly  any  X-chromosome-containing  sperm.
y introducing  these  sex-distorted  males,  the
esearchers  were  able  to  achieve  dramatic  reduc-
ions in  female  mosquitoes.  Ultimately,  there  was
 complete  loss  of the  population  over  six  gener-
tions [44].  While  such  an  approach  is  still  some
ears away  from  ultimate  ﬁeld  deployment,  if  such
n approach  could  be  adapted  to  Aedes  mosquitoes
t nonetheless  presents  a  promising  potential  way
orward  in  mosquito  control  and  hence  control  of
iseases  such  as  ZIKV.  Interestingly,  many  commen-
ators suggest  that  targeting  the  Y  chromosome
ould be  more  effective  in  the  long-term.
iagnosis and treatment of ZIKV
iagnosis  of  ZIKV  infection  is  complicated  by  the
act that  it is  asymptomatic  in  up  to  80%  of  cases.
ymptoms  that  do  occur  tend  to  be  mild  and  non-
peciﬁc,  including  headache,  fever  and  rash  [8,23].
imilarity in  symptoms  to  those  of  other  ﬂavivirus
nfections, such  as  DENV  further  complicates  diag-
osis. Dating  of  the  onset  of  symptoms  tends  to  be
omplicated  by  the  fact  that  there  is  no  abrupt  clin-
cal onset  [9]. There  is,  as  yet,  no  gold  standard
aboratory diagnostic  method  available.  Diagnosis
uring  the  acute  phase  of  the  illness  is  by  detec-
ion of  viral  RNA  in  serum  by  reverse  transcription
CR (ZIKV  RT-PCR)  [10]. For  example,  during  the
utbreak  in  Yap  Island,  a  real-time  RT-PCR  test
argeting  the  viral  envelope  gene  was  used  [2].
nother envelope  targeting  test  using  degenerate
rimers was  designed  based  on  samples  from  West
frica [45].  A  more  recently  developed  test,  which
as the  potential  to  be  converted  to  a  real-time
latform, was  designed  to  target  the  highly  con-
erved  NS5  gene  [46].
The short  viremic  period  of  ZIKV  limits  the  util-
ty of  molecular  diagnostic  techniques  on  serum
amples  to  a  window  of  approximately  3−5  days
ollowing  the  onset  of  infection.  ZIKV  can  also  be
etected  in  saliva  samples  by  ZIKV  RT-PCR  at  a
igher rate  than  for  blood  samples,  but  it  does  not
xtend the  window  of  time  during  which  the  virus
an be  detected  [9,10]. Saliva  samples  provide  an
lternative or  additional  sample  to  blood,  which
ould  be  particularly  useful  in  circumstances  in
hich blood  sample  collection  is  difﬁcult,  for  exam-iew  of  Zika  infection,  epidemiology,  transmission  and
oi.org/10.1016/j.jiph.2016.05.007
le with  infants  and  young  children  [9].  ZIKV  can
lso be  detected  by  RT-PCR  on  urine  samples,  which
ay allow  an  extension  of  the  detection  window.
IKV appears  to  be  detectable  in  urine  for  more
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verview  of  Zika  infection,  epidemiology,  transmiss
han  10  days  after  the  onset  of  disease  [3,10,47].
IKV diagnosis  can  also  be  achieved  by  detection  of
IKV-speciﬁc  IgM  and/or  IgG  antibodies  via  ELISA  or
mmunoﬂuorescence,  starting  from  day  5  or  6 after
he onset  of  symptoms  [10].  However,  results  need
o be  interpreted  carefully  due  to  cross-reactivity
n patients  with  previous  ﬂaviviral  infections,  par-
icularly  DENV  [2,8,10,23].  Recently,  the  release  of
 commercial  kit  for  serological  detection  of  ZIKV
y ELISA  and  indirect  immunoﬂuorescence  is  avail-
ble by  EUROIMMUN.  This  is  in  keeping  with  the
lobal response  strategy  outlined  by  WHO,  which
rioritizes development  of  a  reliable,  affordable
nd rapid  diagnostic  test  [1,48].
There  is  currently  no  vaccine  available  against
IKV, nor  is  there  any  speciﬁc  prophylactic  treat-
ent.  Prevention,  by  following  the  steps  mentioned
bove for  avoiding  mosquito  bites,  is the  best
pproach. Symptom  treatment,  including  getting
ufﬁcient  rest,  drinking  plenty  of  ﬂuids  to  avoid
ehydration  and  taking  medication  for  pain  relief
nd fever  reduction,  such  as  acetaminophen,  is
ecommended  by  the  CDC  and  the  ECDC  [10,11].
reatment  with  acetylsalicylic  acid  and  non-
teroidal anti-inﬂammatory  drugs  is  to  be  avoided,
s they  have  been  associated  with  a  potentially
ncreased risk  of  hemorrhagic  syndrome  in  other
avivirus  infections.  They  have  also  been  associ-
ted with  the  risk  of  Reye’s  syndrome  following
iral infection  in  children  and  teenagers  [10].  Fast-
racking  of  development  of  a  ZIKV  vaccine  and
peciﬁc antivirals  is  a  public  health  priority.  It  is
ritical to  restoring  conﬁdence  and  security  to  peo-
le who  wish  to  have  children  who  reside  in  or  visit
reas in  which  Aedes  mosquitoes  circulate.
uture perspectives
he  WHO  Emergency  Committee  has  identiﬁed  fast-
racking  of  research  into  the  possible  association
f ZIKV  infection  with  the  etiology  of  micro-
ephaly and  neurological  diseases  such  as  GBS,  as
ell as  development  of  vaccines  and  antivirals,
s key  elements  of  the  global  response  strategy
itigate the  impact  of  ZIKV  infection  [1]. Lit-
le is  currently  known  about  the  pathogenesis  of
IKV, as  until  now  it  has  received  relatively  little
ttention  compared  to  other  ﬂaviviruses.  A  recent
tudy  identiﬁed  human  skin  cells  including  dermal
broblasts,  epidermal  keratinocytes  and  immaturePlease  cite  this  article  in  press  as:  Rabaan  AA,  et  al.  Overv
control  measures.  J  Infect  Public  Health  (2016),  http://dx.d
endritic  cells  as  permissive  to  the  ZIKV  isolate  that
aused the  outbreak  in  French  Polynesia  [27]. The
hosphatidylserine  receptor  AXL  was  identiﬁed  as
laying a  major  role  in  ZIKV  entry  into  cells,  while PRESS
and  control  measures  7
ellular  autophagy  enhanced  viral  replication.  An
ntiviral innate  immune  response  was  initiated,
ith production  of  type  I interferons;  ZIKV  was  sen-
itive to  the  antiviral  properties  of  type  I  and  II
nterferons  [27]. Such  studies  cast  light  on  the  inter-
lay between  ZIKV  and  the  human  host,  and  suggest
otential  targets  for  directing  therapies  to  thwart
he virus.  Meanwhile,  at  least  15  research  groups
nd companies  are  currently  researching  ZIKV  vac-
ines, although  most  projects  are  at  an  early  stage.
 DNA  vaccine  under  development  by  the  phar-
aceutical company  Inovio  Pharmaceuticals,  Inc.
n the  USA  has  been  recently  reported  to  induce
obust immune  responses  in  mice  in  preclinical
tudies [49].  Additionally,  Bharat  Biotech  in  India
as ﬁled  a global  patent  for  an  inactivated  vaccine
hat they  claim  could  be  ﬁnished  with  pre-clinical
esting within  5  months  [50]. In  the  meantime,  the
est ‘cure’  is  prevention  via  avoidance  of  mosquito
ites while  the  world  awaits  deﬁnitive  answers  on
he link  between  ZIKV  and  serious  neurological  dis-
ases.
unding
o  funding  sources.
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